Differential expression of CD163 and CD14 marks different stages of maturation and activation in DC3, and an increased frequency of CD163+ CD14+ blood DC3 with proinflammatory function exists in patients with active systemic lupus erythematosus (SLE) [34,35]. The gene discussed is CD163; the disease is systemic lupus erythematosus.